Expert retinologists endorse a proactive treatment regimen for exudative AMD, something that has been advocated by the Instituto de la Màcula for the past 4 years

The November issue of the Revista Española de Patología Macular (Spanish Journal of Macular Pathology) includes the Expert Clinical Guide on the management of exudative age-related macular degeneration (AMD). This document has been agreed by 16 retina specialists from the Spanish Retina and Vitreous Society (SERV), of which Dr. Jordi Monés, director of the Institut … Read more

The Institut de la Màcula celebrates World Sight Day

On the occasion of World Sight Day, the Institut de la Màcula, a center of medical excellence and member of Top Doctors, has launched an awareness and early detection campaign to combat age-related macular degeneration (AMD). The aim of the “Live to See” campaign, which will run until the end of the year, is to … Read more

The Institut de la Màcula i de la Retina, a benchmark in research into treatments for AMD

It is the first accredited center in Europe for the CHROMA medical trial. Lampalizumab is the first therapy to show significant efficacy in slowing the progression of Age-Related Macular Degeneration (AMD), which in its dry or atrophic variant, is the leading cause of non-avoidable blindness in the world in people over 50 years of age. … Read more

Early detection of Macular Degeneration in pharmacies in Catalonia

Thanks to the itinerant campaign “Live to see”, people over 50 years of age can have a check-up for early detection of Age-Related Macular Degeneration (AMD) completely free of charge. This is an initiative of the Institut de la Màcula, a member of Top Doctors, together with Ecoceutics Pharmacies to prevent the visual deterioration resulting … Read more